wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26770678-73C79916-DF1D-43A3-BCD6-1E7D611F15FA
Q26770678-73C79916-DF1D-43A3-BCD6-1E7D611F15FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26770678-73C79916-DF1D-43A3-BCD6-1E7D611F15FA
VEGF pathway targeting agents, vessel normalization and tumor drug uptake: from bench to bedside
P2860
Q26770678-73C79916-DF1D-43A3-BCD6-1E7D611F15FA
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26770678-73C79916-DF1D-43A3-BCD6-1E7D611F15FA
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
5ac17bc86b5ff75afbfcfe3b36b447faeafe14ef
P2860
Ramucirumab plus docetaxel versus placebo plus docetaxel for second-line treatment of stage IV non-small-cell lung cancer after disease progression on platinum-based therapy (REVEL): a multicentre, double-blind, randomised phase 3 trial.